@2024 Afarand., IRAN
ISSN: 2252-0805 The Horizon of Medical Sciences 2015;21(2):105-112
ISSN: 2252-0805 The Horizon of Medical Sciences 2015;21(2):105-112
Effect of Aqueous and Methanolic Extracts of Momordica charantia Fruit on Blood Glucose and Liver Enzymes in Diabetic Rats
ARTICLE INFO
Article Type
Original ResearchAuthors
Kermany H. (1)Shahanipour K. (*)
Nakhaee A.R. (2)
(*) Biochemistry Department, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
(1) Biochemistry Department, Falavarjan Branch, Islamic Azad University, Isfahan, Iran
(2) Biochemistry Department, Medicine Faculty, Zahedan University of Medical Sciences, Zahedan, Iran
Correspondence
Address: Department of Biochemistry, Islamic Azad University, Daneshgah Boulevard, Basij Boulevard, Falavarjan, IranPhone: +983117725585
Fax: +983133390000
shahanipur_k@yahoo.com
Article History
Received: November 30, 2014Accepted: May 10, 2015
ePublished: June 20, 2015
ABSTRACT
Aims
Karela (Momordica charantia), is extensively used in traditional medicine as an antidiabetic drug. The aim of the present study was to analyze the effect of aqueous and methanolic extrarct of Momordica charantia on blood glucose and liver enzymes of rats.
Materials & Methods In this experimental study, 36 adult male Wistar rats were divided into 6 groups (6 rats in each group); control (healthy rats), negative control (diabetic rats by Streptozotocine) and 4 experimental groups (diabetic rats which recived aqueous and methanolic extracts of plant in concentrations of 50 and 100mg/kg of body weight daily for 40 days). The amount of the blood glucose was determined by sequential incision of the tip of the tail once a weak. After completing 40 days, blood was collected from heart of rats and the level of the liver enzymes serum was determined. The results were analysed by ANOVA with repeated measure and one way ANOVA tests in SPSS 19 software.
Findings The effect of different concentrations of aqueous and methanolic extracts on the blood glucose level was significant (p<0.001). Also a significant difference was observed between the amount of the aspartate aminotransfrase (p=0.049) and alanin aminotransfrase (p=0.005) enzymes activity at the two groups of negative control and 50mg/kg of body weight of methanolic extract. Using of 50 and 100mg/kg of body weight of aqueous and methanolic extracts reduced the alkalin phosphatase enzyme activity (p=0.002).
Conclusion Aqueous extract of Momordica charantia fruit have better effect on reducing the blood glucose than methanolic extracts. Both aqueous and methanolic extracts reduce the activity of aspartate aminotransfrase, alanin aminotransfrase and alkalin phosphatase.
Materials & Methods In this experimental study, 36 adult male Wistar rats were divided into 6 groups (6 rats in each group); control (healthy rats), negative control (diabetic rats by Streptozotocine) and 4 experimental groups (diabetic rats which recived aqueous and methanolic extracts of plant in concentrations of 50 and 100mg/kg of body weight daily for 40 days). The amount of the blood glucose was determined by sequential incision of the tip of the tail once a weak. After completing 40 days, blood was collected from heart of rats and the level of the liver enzymes serum was determined. The results were analysed by ANOVA with repeated measure and one way ANOVA tests in SPSS 19 software.
Findings The effect of different concentrations of aqueous and methanolic extracts on the blood glucose level was significant (p<0.001). Also a significant difference was observed between the amount of the aspartate aminotransfrase (p=0.049) and alanin aminotransfrase (p=0.005) enzymes activity at the two groups of negative control and 50mg/kg of body weight of methanolic extract. Using of 50 and 100mg/kg of body weight of aqueous and methanolic extracts reduced the alkalin phosphatase enzyme activity (p=0.002).
Conclusion Aqueous extract of Momordica charantia fruit have better effect on reducing the blood glucose than methanolic extracts. Both aqueous and methanolic extracts reduce the activity of aspartate aminotransfrase, alanin aminotransfrase and alkalin phosphatase.
CITATION LINKS
[1]Fallah Huseini H, Fakhrzadeh H, Larijani B, Shikh Samani . Review of anti-diabetic medicinal plant used in traditional medicine. J Med Plants. 2006;1 Suppl 2:S1-8.
[2]Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res. 2007;125(3):451-72.
[3]Matthaei S, Stumvoll M, Kellerer M, Häring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21(6):585-618.
[4]Esteghamati A, Ashraf H, Khalilzadeh O, Rashidi A, Mohammad K, Asgari F, et al. Trends of diabetes according to body mass index levels in Iran: Results of the national surveys of risk factors of non-communicable diseases (1999-2007). Diabet Med. 2010;27(11):1233-40.
[5]Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran lipid and glucose study. BMC Public Health. 2008;8:176.
[6]Gilbert MP, Pratley RE. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Am J Med. 2009;122 Suppl 2:S11-24.
[7]Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2(2):137-89.
[8]Xing Jiu H, Yang Kyn C, Hyung Soon I, Oktay Y, Euisik Y, Hak Sung K, et al. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors. 2006;6(7):756-82.
[9]Praff DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266-71.
[10]Joseph B, Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013;3(2):93-102.
[11]Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res. 1996;33(1):1-4.
[12]Ananya P, Sarmistha SR. Medicinal uses and molecular identification of two Momordica charantia varieties: A review. EJBIO. 2010;6(2):43-51.
[13]Chaudhari BP, Chaware VJ, Joshi YR, Biyani KR. Hepatoprotective activity of hydroalcoholic extract of Momordica charantia linn. leaves against carbon tetra chloride induced hepatopathy in rats. Int J Chem Tech Res. 2009;1(2):355-8.
[14]Venkatesh S, Reddy GD, Reddy BM, Ramesh M, Rao AV. Antihyperglycemic activity of caralluma attenuata. Fitoterapia. 2003;74(3):274-9.
[15]Zareba G, Serradell R, Castaner R, Davies SL, Prous J, Mealy N. Phytotherapies for diabetes. Drugs Future. 2005;30:1253-82.
[16]Abdollahi M, Zuki ABZ, Goh YM, Rezaeizadeh A, Noordin MM. The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. Afr J Biotechnol. 2010;9(31):5004-12.
[17]Hossain MS, Ahmed M, Islam A. Hypolipidemic and hepatoprotective effects of different fractions of methanolic extract of Momordica charantia (LINN.) in alloxan induced diabetic rats. Int J Pharm Sci Res. 2011;2(3):601-7.
[18]Shetty AK, Kumar GS, Sambaiah K, Salimath PV. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr. 2005;60(3):109-12.
[19]Matheka DM ,Kiama TN, Alkizim FO, Bakachi F. Glucose-lowering effects of Momordica charantia in healthy rats. Afr J Diabets Med. 2011;19(2):15-9.
[20]Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J. 1981;282(6279):1823-4.
[21]Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract. 1998;40(3):145-51.
[22]Karunanayake EH, Jeevathayaparan S, Tennekoon KH. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol. 1990;30(2):199-204.
[23]Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem. 2004;261(1-2):63-70.
[24]Colev V, Bădescu M, Păduraru I, Mândreci I, Bohotin C. The zinc-metabolic disorder relation in experimental diabetes mellitus. Rom J Intern Med. 1994;32(1):71-5.
[25]Shibib BA, Khan LA, Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J. 1993;292(Pt 1):267-70.
[26]Abd El Sattar El Batran S, El Gengaihi SE, El Shabrawy OA. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol. 2006;108(2):236-42.
[2]Srinivasan K, Ramarao P. Animal models in type 2 diabetes research: An overview. Indian J Med Res. 2007;125(3):451-72.
[3]Matthaei S, Stumvoll M, Kellerer M, Häring HU. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev. 2000;21(6):585-618.
[4]Esteghamati A, Ashraf H, Khalilzadeh O, Rashidi A, Mohammad K, Asgari F, et al. Trends of diabetes according to body mass index levels in Iran: Results of the national surveys of risk factors of non-communicable diseases (1999-2007). Diabet Med. 2010;27(11):1233-40.
[5]Hadaegh F, Bozorgmanesh MR, Ghasemi A, Harati H, Saadat N, Azizi F. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran lipid and glucose study. BMC Public Health. 2008;8:176.
[6]Gilbert MP, Pratley RE. Efficacy and safety of incretin-based therapies in patients with type 2 diabetes mellitus. Am J Med. 2009;122 Suppl 2:S11-24.
[7]Marles RJ, Farnsworth NR. Antidiabetic plants and their active constituents. Phytomedicine. 1995;2(2):137-89.
[8]Xing Jiu H, Yang Kyn C, Hyung Soon I, Oktay Y, Euisik Y, Hak Sung K, et al. Aspartate aminotransferase (AST/GOT) and alanine aminotransferase (ALT/GPT) detection techniques. Sensors. 2006;6(7):756-82.
[9]Praff DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med. 2000;342(17):1266-71.
[10]Joseph B, Jini D. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pac J Trop Dis. 2013;3(2):93-102.
[11]Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res. 1996;33(1):1-4.
[12]Ananya P, Sarmistha SR. Medicinal uses and molecular identification of two Momordica charantia varieties: A review. EJBIO. 2010;6(2):43-51.
[13]Chaudhari BP, Chaware VJ, Joshi YR, Biyani KR. Hepatoprotective activity of hydroalcoholic extract of Momordica charantia linn. leaves against carbon tetra chloride induced hepatopathy in rats. Int J Chem Tech Res. 2009;1(2):355-8.
[14]Venkatesh S, Reddy GD, Reddy BM, Ramesh M, Rao AV. Antihyperglycemic activity of caralluma attenuata. Fitoterapia. 2003;74(3):274-9.
[15]Zareba G, Serradell R, Castaner R, Davies SL, Prous J, Mealy N. Phytotherapies for diabetes. Drugs Future. 2005;30:1253-82.
[16]Abdollahi M, Zuki ABZ, Goh YM, Rezaeizadeh A, Noordin MM. The effects of Momordica charantia on the liver in streptozotocin-induced diabetes in neonatal rats. Afr J Biotechnol. 2010;9(31):5004-12.
[17]Hossain MS, Ahmed M, Islam A. Hypolipidemic and hepatoprotective effects of different fractions of methanolic extract of Momordica charantia (LINN.) in alloxan induced diabetic rats. Int J Pharm Sci Res. 2011;2(3):601-7.
[18]Shetty AK, Kumar GS, Sambaiah K, Salimath PV. Effect of bitter gourd (Momordica charantia) on glycaemic status in streptozotocin induced diabetic rats. Plant Foods Hum Nutr. 2005;60(3):109-12.
[19]Matheka DM ,Kiama TN, Alkizim FO, Bakachi F. Glucose-lowering effects of Momordica charantia in healthy rats. Afr J Diabets Med. 2011;19(2):15-9.
[20]Leatherdale BA, Panesar RK, Singh G, Atkins TW, Bailey CJ, Bignell AH. Improvement in glucose tolerance due to Momordica charantia (karela). Br Med J. 1981;282(6279):1823-4.
[21]Ahmed I, Adeghate E, Sharma AK, Pallot DJ, Singh J. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract. 1998;40(3):145-51.
[22]Karunanayake EH, Jeevathayaparan S, Tennekoon KH. Effect of Momordica charantia fruit juice on streptozotocin-induced diabetes in rats. J Ethnopharmacol. 1990;30(2):199-204.
[23]Ahmed I, Adeghate E, Cummings E, Sharma AK, Singh J. Beneficial effects and mechanism of action of Momordica charantia juice in the treatment of streptozotocin-induced diabetes mellitus in rat. Mol Cell Biochem. 2004;261(1-2):63-70.
[24]Colev V, Bădescu M, Păduraru I, Mândreci I, Bohotin C. The zinc-metabolic disorder relation in experimental diabetes mellitus. Rom J Intern Med. 1994;32(1):71-5.
[25]Shibib BA, Khan LA, Rahman R. Hypoglycaemic activity of Coccinia indica and Momordica charantia in diabetic rats: Depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6-bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J. 1993;292(Pt 1):267-70.
[26]Abd El Sattar El Batran S, El Gengaihi SE, El Shabrawy OA. Some toxicological studies of Momordica charantia L. on albino rats in normal and alloxan diabetic rats. J Ethnopharmacol. 2006;108(2):236-42.